{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:40:01Z","timestamp":1758973201104,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.annder.2012.01.019","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T09:05:00Z","timestamp":1332493500000},"page":"282-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9ruption cutan\u00e9e atypique au cours d\u2019un syndrome des antiphospholipides"],"prefix":"10.1016","volume":"139","author":[{"given":"P.","family":"Gelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.-R.","family":"De Ybarlucea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Prophette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Celerier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2012.01.019_bib0005","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2012.01.019_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/ard.52.3.219","article-title":"Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study","volume":"52","author":"Naldi","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2012.01.019_bib0015","first-page":"7","article-title":"Le syndrome des antiphospholipides","volume":"128","author":"Petit","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.01.019_bib0020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2012.01.019_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyaki","year":"2006","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.annder.2012.01.019_bib0030","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of litt\u00e9rature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.annder.2012.01.019_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0025-7125(05)70509-5","article-title":"Pathogenesis and treatment of the antiphospholipid antibody syndrome","volume":"81","author":"Petri","year":"1997","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.annder.2012.01.019_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2133.1989.tb04170.x","article-title":"Skin lesions associated with circulating lupus anticoagulant","volume":"120","author":"Alegre","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0045","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases","volume":"52","author":"Franc\u00e8s","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2012.01.019_bib0050","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alar\u00e7on-Segovia","year":"1989","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-4632.2004.01939.x","article-title":"Cutaneous manifestations associated with antiphospholipid antibodies","volume":"43","author":"Di\u00f3genes","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.46.3.251","article-title":"Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of the extremities","volume":"46","author":"Bird","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2012.01.019_bib0065","article-title":"Manifestations dermatologiques du syndrome des antiphospholipides","author":"Franc\u00e8s","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2012.01.019_bib0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0190-9622(97)80283-6","article-title":"Antiphospholipid syndrome and the skin","volume":"36","author":"Gibson","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1989.tb04178.x","article-title":"Discoid lupus erythematosus associated with the anticardiolipin syndrome","volume":"120","author":"Berth-Jones","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0190-9622(88)70159-0","article-title":"Histopathologic and immunofluorecence study of skin lesions associated with circulating lupus anticoagulant","volume":"19","author":"Alegre","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(86)70159-X","article-title":"Cutaneous manifestations associated with the presence of the lupus anticoagulant","volume":"15","author":"Grob","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0090","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2012.01.019_bib0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria ant treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2012.01.019_bib0100","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381200052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381200052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:58:51Z","timestamp":1758970731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S015196381200052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S015196381200052X"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2012.01.019","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9ruption cutan\u00e9e atypique au cours d\u2019un syndrome des antiphospholipides","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2012.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}